Selected article for: "active thrombopoiesis and acute puumala hantavirus disease"

Author: Laine, Outi; Joutsi-Korhonen, Lotta; Lassila, Riitta; Huhtala, Heini; Vaheri, Antti; Mäkelä, Satu; Mustonen, Jukka
Title: Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection
  • Document date: 2016_12_30
  • ID: jhcc6eex_29
    Snippet: In conclusion, serum TPO is upregulated and the production of platelets is enhanced during acute Puumala hantavirus disease. Serum TPO does not predict disease severity in terms of AKI. Biomarkers of thrombin generation and especially fibrinolysis are high in the absence of clinical thrombosis or major bleedings, and they associate with adverse kidney outcome. As thrombopoiesis is active and the proportion of young platelets is high, measuring th.....
    Document: In conclusion, serum TPO is upregulated and the production of platelets is enhanced during acute Puumala hantavirus disease. Serum TPO does not predict disease severity in terms of AKI. Biomarkers of thrombin generation and especially fibrinolysis are high in the absence of clinical thrombosis or major bleedings, and they associate with adverse kidney outcome. As thrombopoiesis is active and the proportion of young platelets is high, measuring the activity of platelet-derived MPs with flow cytometry might clarify the role of MPs in the pathogenesis of HFRS.

    Search related documents:
    Co phrase search for related documents
    • AKI term and disease severity: 1
    • AKI term and kidney outcome: 1
    • clinical thrombosis and disease severity: 1, 2, 3, 4, 5, 6
    • clinical thrombosis and flow cytometry: 1
    • clinical thrombosis and major bleeding: 1, 2, 3
    • disease severity and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease severity and HFRS pathogenesis: 1, 2, 3
    • disease severity and kidney outcome: 1, 2, 3, 4
    • disease severity and major bleeding: 1, 2, 3, 4, 5, 6
    • disease severity predict and flow cytometry: 1, 2, 3, 4, 5
    • flow cytometry and kidney outcome: 1